FDA approves two biosimilars to blockbuster eye drug Eylea

[cafead]

via The U.S. Food and Drug Administration on Monday approved two close copies of Regeneron Pharmaceuticals' (REGN.O) blockbuster eye drug, Eylea, potentially hurting the company's efforts to market a higher dose version of the treatment.

article source